Tehran University of Medical Sciences, School of Dentistry
Tehran, 1439955991, Iran
NCT Number: NCT07434141
The goal of this clinical trial is to compare post-treatment pain after root canal therapy in adults with irreversible pulpitis using different root canal sealers. The study will also evaluate the need for pain medication after treatment.
The main questions this study aims to answer are:
Does the type of root canal sealer affect the intensity of pain after treatment?
Does the type of sealer influence the number of analgesic tablets taken by participants?
How does pain change over time after treatment with different sealers?
Researchers will compare two bioceramic sealers (EndoSeal TCS and NeoSeal) with a resin-based sealer (AH Plus) to determine their effects on post-endodontic pain.
Participants will:
Receive root canal treatment using one of the study sealers
Report their pain intensity at specific time points after treatment
Record the number of analgesic tablets taken during the follow-up period
This study is active but is not currently recruiting participants.
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Tehran, 1439955991, Iran
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bioceramic, premixed calcium silicate-based root canal sealer used for obturation with the single-cone technique during root canal treatment
Fast-setting calcium silicate-based bioceramic root canal sealer used for obturation with the single-cone technique during root canal treatment
Epoxy resin-based root canal sealer used for obturation with the single-cone technique during root canal treatment
Time frame: Pain will be assessed at 6, 12,18, 24, and 48 hours post-treatment
Pain intensity experienced by participants after root canal treatment will be measured using a Visual Analog Scale (VAS; 0-10 numeric rating scale), where:
0 = no pain
10 = worst imaginable pain
Higher scores indicate greater pain intensity (worse outcome).
Participants will also record the number of analgesic tablets consumed during the first 48 hours after treatment.
The maximum VAS pain score recorded during the first 48 hours will be considered the primary outcome
Time frame: Within 48 hours post-treatment
Total number of analgesic tablets consumed by participants during the first 48 hours after treatment
Tehran University of Medical Sciences
Other
Comparative Analysis of Postoperative Pain in Symptomatic Irreversible Pulpitis Teeth Following Single Cone Obturation Using Three Different Sealers: A Randomized Clinical Trial
Acronym: POP-RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627867
Symptomatic Irreversible Pulpitis (SIP)
Cairo, New Cairo, Egypt
View Trial DetailsNCT07191990
Neurologic Manifestations, Pain
Cairo, New Cairo, Egypt
View Trial DetailsNCT07290049
Neurologic Manifestations, Pain
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT07704463
Symptomatic Irreversible Pulpitis (SIP)
Alexandria, Egypt
View Trial Details